| CN

Advisory Center

News about Immunochina

Immunochina CAR-T therapy clinical data unveiled at ASCO: 3-month complete remission rate of 86% 06-042018

Chairman of Immunochina, Dr. He Ting, gave general assembly speech and announced donation feedback for Tsinghua x-lab on the fifth anniversary since Tsinghua x-lab’s establishment 05-282018

Immunochina became one of the 10 most noteworthy innovative pharmaceuticals companies in China in 2018 05-252018

Immunochina and Thermo Fisher Scientific to realize the digitization of cell therapy sample tracking 05-072018

The latest progress in the treatment of advanced leukemia from Immunochina 04-172018